Skip to main content
Clinical Trials/NL-OMON46895
NL-OMON46895
Completed
Not Applicable

Cardioband Adjustable Annuloplasty System For Transcatheter Repair of Mitral Valve Regurgitation - Cardioband For Transcatheter MV Repair

Valtech Cardio LTD0 sites10 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
mitral valve regurgitation
Sponsor
Valtech Cardio LTD
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Valtech Cardio LTD

Eligibility Criteria

Inclusion Criteria

  • \* Age \> 18 years
  • \* Moderate to severe functional MR
  • \* Symptomatic Patients (NYHA ClassII\-IV) despite optimal medical therapy , including CRT if indicated.
  • \* LVEF \* 25%, LVEDD \* 70mm
  • \* Subject is high risk to undergo MV surgery (as assessed by a cardiac surgeon and a cardiologist at the site, and according to ESC/EACTS guidelines on the management of valvular heart disease)
  • \* Transseptal catheterization and femoral vein access is determined to be feasible
  • \* Subject is able and willing to give informed consent and follow protocol procedures

Exclusion Criteria

  • \* Active bacterial endocarditis
  • \* Severe organic lesions with retracted chordae or congenital malformations with lack of valvular tissue
  • \* Heavily calcified annulus or leaflets
  • \* Subjects in whom transesophageal echocardiography is contraindicated
  • \* Untreated clinically significant CAD requiring revascularization
  • \* Any percutaneous coronary, carotid, endovascular intervention or carotid surgery within 30 days or any coronary or endovascular surgery within 3 months
  • \* CVA or TIA within 6 months or severe carotid stenosis (\>70% by Ultra sound)
  • \* Renal insufficiency requiring dialysis
  • \* Life expectancy of less than twelve months
  • \* Patient is pregnant (urine HCG test result positive) or lactating

Outcomes

Primary Outcomes

Not specified

Similar Trials